Index Adjustments on the Occasion of the Ordinary Index Review

SIX has decided to make changes to the index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 15 September 2023 after closing. The adjustment takes effect on 18 September 2023.

Index Adjustments on the Occasion of the Ordinary Index Review
Published at
Medium
Media

Changes to the SMI® and SPI®20 index baskets

NO CHANGES TO THE INDEX COMPOSITION

  


Changes to the SMIM® index basket

Admission to the SMIM®

BKW N

CH0130293662


Exclusion from the SMIM®

DocMorris N

CH0042615283


Changes to the SLI® index basket

Admission to the SLI®

SIG Group N

CH0435377954

ROCHE I

CH0012032113


Exclusion from the SLI®

TEMENOS N

CH0012453913

ams-OSRAM

AT0000A18XM4


SLI® 9% cappings

Based on the SLI® index rules, section 7.15.4, and according to the capping selection list 9%1, the weight of the following securities will be limited to 9%:

NESTLE N

 CH0038863350

ROCHE GS

 CH0012032048

NOVARTIS N

 CH0012005267

RICHEMONT N

 CH0210483332

 

Changes to the SPI® Small, Mid and Large index baskets

Changes from SPI® Mid to SPI® Large

NO CHANGES TO THE INDEX COMPOSITION

  


Changes from SPI® Large to SPI® Mid

NO CHANGES TO THE INDEX COMPOSITION

  


Changes from SPI® Small to SPI® Mid

YPSOMED HLDG

 CH0019396990

U-BLOX N

 CH0033361673

SKAN N

 CH0013396012

 

Changes from SPI® Mid to SPI® Small

DocMorris N

 CH0042615283

MEDMIX N

 CH1129677105

POLYPEPTIDE N

 CH1110760852


Changes to the SXI Life Sciences®

Exclusion from the SXI Life Sciences®

SHL TELEMEDICINE N

 IL0010855885

EVOLVA N

 CH1262055788

IVF HARTMANN N

 CH0187624256

RELIEF THERAPEUTICS N

 CH1251125998

OBSEVA N

 CH1260041939

 

Changes to the SXI Bio+Medtech®

Exclusion from the SXI Bio+Medtech®

SHL TELEMEDICINE N

 IL0010855885

EVOLVA N

 CH1262055788

IVF HARTMANN N

 CH0187624256

RELIEF THERAPEUTICS N

 CH1251125998

OBSEVA N

 CH1260041939

 

Changes to the SXI Swiss Real Estate® Funds

Admission to SXI Swiss Real Estate® Funds

SOLVL 61 PRT

 CH0002785456


Exclusion from SXI Swiss Real Estate® Funds

UBS FONCIPARS

 CH0014420852


Changes to the SXI Swiss Real Estate® Shares

NO CHANGES TO THE INDEX COMPOSITION

  

 

Further Links

The equity selection list, which is compiled four times a year on the basis of the admission and exclusion criteria, is available on the website[1]:

[1] Access to the Closed User Group required.

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX serves the Swiss and Spanish financial centers and a broad international client base, offering stable and efficient infrastructure services. SIX operates stock exchanges and provides services in securities, financial information as well as the payments business. The company is owned by its users (about 120 financial institutions). With over 4,400 employees and a presence in 20 countries, SIX generated operating income of CHF 1.6 billion and EBITDA of CHF 443.7 million in 2024.
www.six-group.com

View all Media Releases